CONSULTANT - Malaria Chemoprevention
Brazzaville
- Organization: WHO - World Health Organization
- Location: Brazzaville
- Grade: Consultancy - International Consultant - Internationally recruited Contractors Agreement
-
Occupational Groups:
- Malaria, Tuberculosis and other infectious diseases
- Closing Date: Closed
| ||||||||||||||||
The 2022 World Malaria Report documented 247 million cases of malaria worldwide, and 619 000 malaria deaths. The World Health Organization’s (WHO) Africa Region carried about 96% of these cases (estimated 234 million cases) and 96% of these deaths (593,000 deaths), with children aged under 5 years being most vulnerable and accounting for most (about 79%) of malaria deaths. Member States are implementing the priority interventions and actions to accelerate achieving the set targets in the region as stated in the framework for implementing the Global Technical Strategy for Malaria in the African Region. However, after many years of progress, the trajectory of malaria control has plateaued and there is urgent need for these approaches to evolve. Despite the progress in malaria prevention and control in the region, there are gaps in uptake of available interventions. Among the malaria preventive measures are a set of chemoprevention interventions based on the use of malaria medicines to reduce the burden of severe malaria and death among populations at risk of malaria, especially young children and pregnant women. According to the latest WHO malaria guideline recommendations (version of 25 November 2022) - these include Intermittent-Preventive-Treatment in Pregnancy (IPTp), Perennial malaria chemoprevention (PMC), formerly known as Intermittent Preventive Treatment in infants (IPTi), Seasonal-Malaria-Chemoprevention (SMC), Intermittent preventive treatment of malaria in school -aged children (IPTsc), Post-discharge malaria chemoprevention (PDMC) and Mass Drug Administration (MDA). To maximize the value of the implementation of preventive therapies that are recommended especially for the most vulnerable groups in malaria – endemic areas of sub-Saharan Africa, and the opportunity afforded by the WHO updated/revised chemoprevention recommendations, consultants are needed to support the adoption, implementation and scale up of chemoprevention interventions in the region. The purpose of this consultancy is to to ensure that member states are adequately supported, and also appropriate guidance provided in the adoption and implementation of malaria chemoprevention interventions Objectives: The overall objective is to ensure that member states are adequately supported, and also appropriate guidance provided in the adoption and implementation of malaria chemoprevention interventions and specifically: The specific objectives are as follows:
Organizational Context Under the guidance of the Tropical and Vector Borne Diseases (TVD) and Vaccine Preventable Diseases (VPD) team leaders within the AFRO UCN cluster, the consultant will work closely with the chemoprevention focal persons in the TVD unit and Global Malaria Programme (GMP) to perform / carry out the tasks; Support countries in the adoption, adaptation and/or implementation of malaria chemoprevention interventions (policy development, strategic planning and identification of needs for capacity strengthening for chemoprevention), Advocate for and support subnational tailoring activities and ensure chemoprevention interventions are appropriately considered in national policy documents and national strategic plans, Facilitate resistance monitoring for chemoprevention interventions through use of the ChemoPrevention Efficacy Study (CPES) protocol and submit comprehensive report upon completion of the mission | ||||||||||||||||
| ||||||||||||||||
Outline clear tasks and deliverables, to be carried out in the framework of the background described above. These need to be time-bound and specific.
Summary of Assigned Duties: Under the direct Under the guidance of the Tropical and Vector Borne Diseases (TVD) and Vaccine Preventable Diseases (VPD) team leaders within the AFRO UCN cluster, the consultant will work closely with the chemoprevention focal persons in the TVD unit and Global Malaria Programme (GMP) to perform / carry out the following tasks:
| ||||||||||||||||
| ||||||||||||||||
Identify the educational qualifications and expertise needed for the terms of reference outlined above. Educational Qualifications Master’s degree in Epidemiology, public health, parasitology or infectious diseases. Experiences Essential:
Desirable.
Competencies: Candidate should be able to:
Languages and level required
English/Expert or French/Expert or Portuguese/Expert A good working knowledge of a second international language (English, French or Portuguese) would be an advantage. | ||||||||||||||||
| ||||||||||||||||
Please specify any expected travel(s): dates, location and purpose. A living expense is payable to on-site consultants – please refer to Information Note 08/2019 for details on eligibility.
Place of assignment: WHO Regional Office, Brazzaville, Republic of Congo
| ||||||||||||||||
5. Remuneration and budget (travel costs excluded) | ||||||||||||||||
Proposed level: P4 or P5 based on qualification and experience.
Currency: United States Dollars (USD)
Work schedule (if applicable) : Please refer to Information Note 09/2021 for guidance on rates for consultants.
|
However, we have found similar vacancies for you: